Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Johnson & Johnson Enterprise Innovation Inc.
Royal Marsden NHS Foundation Trust
Seagen Inc.
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Gustave Roussy, Cancer Campus, Grand Paris
R-Pharm
National Cancer Institute (NCI)
University of Southern California
Sanford Health
EMD Serono
Dana-Farber Cancer Institute
Eli Lilly and Company
Thomas Jefferson University
National Cancer Institute (NCI)
AstraZeneca
Dana-Farber Cancer Institute
Taiho Pharmaceutical Co., Ltd.
University of Birmingham
University College, London
Vanderbilt-Ingram Cancer Center
Shanghai Jiao Tong University School of Medicine
Emory University
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
RTOG Foundation, Inc.
Jiangsu HengRui Medicine Co., Ltd.
National Cancer Institute (NCI)
Jiangsu HengRui Medicine Co., Ltd.
Fifth Affiliated Hospital, Sun Yat-Sen University
UNC Lineberger Comprehensive Cancer Center
Ruijin Hospital
University Health Network, Toronto
AstraZeneca
University of Cincinnati
China Medical University Hospital
Canadian Cancer Trials Group
National Institutes of Health Clinical Center (CC)
Emory University
Ohio State University Comprehensive Cancer Center
University of Washington
Eli Lilly and Company
Critical Outcome Technologies Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Daiichi Sankyo
Ohio State University Comprehensive Cancer Center
Loma Linda University
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Curis, Inc.